Highly-loaded protein nanocarriers prepared by Flash NanoPrecipitation with hydrophobic ion pairing

被引:9
作者
Ristroph, Kurt D. [1 ]
Rummaneethorn, Paradorn [1 ]
Johnson-Weaver, Brandi [2 ]
Staats, Herman [2 ]
Prudhomme, Robert K. [1 ]
机构
[1] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA
[2] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27708 USA
基金
美国国家科学基金会;
关键词
Hydrophobic ion pairing; Ovalbumin; Lysozyme; Drug delivery; Nanocarrier; Flash NanoPrecipitation; DRUG-DELIVERY; COMPLEX; NANOPARTICLES; INSULIN; MICROPARTICLES; DOXORUBICIN; LYSOZYME; CELLS; ACID;
D O I
10.1016/j.ijpharm.2021.120397
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The efficient encapsulation of therapeutic proteins into delivery vehicles, particularly without loss of function, remains a significant research hurdle. Typical liposomal formulations achieve drug loadings on the order of 3-5% and encapsulation efficiencies around 50%. We demonstrate the encapsulation of model proteins with isoelectric points above and below pH 7 into nanocarriers (NCs) with protein loadings as high as 46% and encapsulation efficiencies above 95%. This is done by combining the continuous nanofabrication process Flash Nano Precipitation (FNP) with the technique of hydrophobic ion pairing by forming and encapsulating an ionic complex within a nanocarrier stabilized by a block copolymer surface layer. We complex and encapsulate lysozyme with two anionic hydrophobic counterions, sodium oleate and sodium dodecyl sulfate, using either a pre-formed complex or in situ pairing. The strategy successfully forms NCs similar to 150 nm in diameter and achieves encapsulation efficiencies over 95%. Protein release rate from the NCs in physiological conditions and the bioactivity of released lysozyme are measured, and both are found to vary with the complexing counterion and the protein/counterion ratio used during formulation. Protein release on the time scale of weeks is observed, and up to 100% bioactivity is measured from released lysozyme. 16 quaternary ammonium cationic counterions are tested to encapsulate ovalbumin in 32 formulations. Of these, 19 successfully form similar to 150 nm NCs with loadings up to 29% and encapsulation efficiencies up to 88%. We divide the formulations into four regimes and identify chemical factors responsible for the success or failure of a given counterion to formulate NCs with the desirable size, loading, and encapsulation efficiency. A successful ovalbumin NC formulation was then tested in vivo in a mouse nasal vaccine model and found to induce a higher titer of OVA-specific IgG than unencapsulated ovalbumin. Taken together, these findings suggest that Flash NanoPrecipitation with hydrophobic ion pairing is an attractive platform for encapsulating high molecular weight proteins into NCs. In particular, the ability to tune protein release rate by varying the counterion or protein/counterion ratio used during formulation is a useful feature.
引用
收藏
页数:9
相关论文
共 37 条
[1]   Liquid crystalline assembly for potential combinatorial chemo-herbal drug delivery to lung cancer cells [J].
Abdelaziz, Hadeer M. ;
Elzoghby, Ahmed O. ;
Helmy, Maged W. ;
Samaha, Magda W. ;
Fang, Jia-You ;
Freag, May S. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 :499-517
[2]   Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo [J].
Ashton, Susan ;
Song, Young Ho ;
Nolan, Jim ;
Cadogan, Elaine ;
Murray, Jim ;
Odedra, Rajesh ;
Foster, John ;
Hall, Peter A. ;
Low, Susan ;
Taylor, Paula ;
Ellston, Rebecca ;
Polanska, Urszula M. ;
Wilson, Joanne ;
Howes, Colin ;
Smith, Aaron ;
Goodwin, Richard J. A. ;
Swales, John G. ;
Strittmatter, Nicole ;
Takats, Zoltan ;
Nilsson, Anna ;
Andren, Per ;
Trueman, Dawn ;
Walker, Mike ;
Reimer, Corinne L. ;
Troiano, Greg ;
Parsons, Donald ;
De Witt, David ;
Ashford, Marianne ;
Hrkach, Jeff ;
Zale, Stephen ;
Jewsbury, Philip J. ;
Barry, Simon T. .
SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (325)
[3]  
Asuman BozkirB.D., 2015, Journal of Nanomedicine Nanotechnology, DOI [DOI 10.4172/2157-7439.1000259, 10.4172/2157-7439.1000259]
[4]   Preparation and Characterization of Insulin-Loaded Lipid-Based Microspheres Generated by Electrospray [J].
Bussano, R. ;
Chirio, D. ;
Costa, L. ;
Turci, F. ;
Trotta, M. .
JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2011, 32 (10) :1524-1530
[5]   Protected Peptide Nanoparticles: Experiments and Brownian Dynamics Simulations of the Energetics of Assembly [J].
Chen, Ting ;
D'Addio, Suzanne M. ;
Kennedy, Michael T. ;
Swietlow, Aleksander ;
Kevrekidis, Ioannis G. ;
Panagiotopoulos, Athanassios Z. ;
Prud'homme, Robert K. .
NANO LETTERS, 2009, 9 (06) :2218-2222
[6]   Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation [J].
Cui, Fude ;
Shi, Kai ;
Zhang, Liqiang ;
Tao, Anjin ;
Kawashima, Yoshiaki .
JOURNAL OF CONTROLLED RELEASE, 2006, 114 (02) :242-250
[7]   Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing [J].
Dai, Wei-Guo ;
Dong, Liang C. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 336 (01) :58-66
[8]   A comprehensive model for the cellular uptake of cationic cell-penetrating peptides [J].
Duchardt, Falk ;
Fotin-Mleczek, Mariola ;
Schwarz, Heinz ;
Fischer, Rainer ;
Brock, Roland .
TRAFFIC, 2007, 8 (07) :848-866
[9]   Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme [J].
Gaudana, Ripal ;
Gokulgandhi, Mitan ;
Khurana, Varun ;
Kwatra, Deep ;
Mitra, Ashim K. .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (03) :752-759
[10]   Biological activity of lysozyme after entrapment in poly (d,l-lactide-co-glycolide)-microspheres [J].
Ghaderi, R ;
Carlfors, J .
PHARMACEUTICAL RESEARCH, 1997, 14 (11) :1556-1562